Figure 3

![Figure 3: Exploratory data from the probiotic combination trial in IBS subjects illustrate relationships between psychological measures and gastrointestinal symptom outcomes. The Bifidobacterium longum strains 1714 and 35642 were evaluated for their combined effects on stress-related and visceral endpoints.]()

> Source: David Groeger et al. "Interactions between symptoms and psychological status in irritable bowel syndro." *Neurogastroenterology and motility*, 2023. PMID: [36178333](https://pubmed.ncbi.nlm.nih.gov/36178333/)

<figure>
  <img src="" alt="Exploratory data from the probiotic combination trial in IBS subjects illustrate relationships between psychological measures and gastrointestinal symptom outcomes. The Bifidobacterium longum strains 1714 and 35642 were evaluated for their combined effects on stress-related and visceral endpoints." />
  <figcaption>Figure 3. Exploratory data from the probiotic combination trial in IBS subjects illustrate relationships between psychological measures and gastrointestinal symptom outcomes. The Bifidobacterium longum strains 1714 and 35642 were evaluated for their combined effects on stress-related and visceral endpoints.<br>  Source: David Groeger et al. "Interactions between symptoms and psychological status in irritable bowel syndro." <em>Neurogastroenterology and motility</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36178333/">36178333</a></figcaption>
</figure>